Novo Nordisk produces life-saving medicine for millions of people living with diabetes and other serious chronic diseases. This is a tremendous responsibility that we take with us in everything we do, relying on our scientific expertise and deep disease understanding to help people achieve better health.
When it comes to climate change, we also rely on scientific experts. Our accountability and level of responsibility must align with the recommendations from the scientific community. We refer to the findings of the UN Intergovernmental Panel on Climate Change (IPCC), acknowledging the overwhelming scientific evidence and agree with the need to keep the temperature increase below 2°C.
Novo Nordisk has committed to set a science-based emission reduction target in line with the Science Based Targets Initiative’s Call to Action criteria. We are using methods endorsed by the initiative to develop our targets. Our Scope 1 and 2 initiatives include renewable power at all production sites, bio-natural gas and biomass based steam supply in Denmark as well as reduced emission from the car fleet.
Novo Nordisk has signed up for the RE100 initiative and pledged that all our electricity consumption from production will come from renewable sources by 2020.